Overview
Welcome to Dwaey, specifically on DALACIN-C 600mg/4ml I.M/I.V Injection page.
This medicine contains an important and useful components, as it consists of Clindamycin (as phosphate).
DALACIN-C 600mg/4ml I.M/I.V is available in the market in concentration 150mg/ml and in the form of Injection.
PHARMACIA N.V/S.A. is the producer of DALACIN-C 600mg/4ml I.M/I.V and it is imported from BELGIUM, The most popular alternatives of DALACIN-C 600mg/4ml I.M/I.V are listed downward .
Allopurinol is an inhibitor of the enzyme xanthine oxidase which converts hypoxanthine to xanthine then uric acid. The reduced production of uric acid relieves all symptoms associated with hyperuricaemia and gout. Inhibition of xanthine oxidase leads to accumulation of its substrates hypoxanthine and xanthine but since their renal clearance is more than 10 times that of uric acid, there is no risk of nephrolithiasis.
Ensure adequate fluid intake. Prophylactically with an anti-inflammatory or colchicine for at least 1 mth. Withdraw immediately when sensitivity (skin rash, etc) appears. Pregnancy, lactation. Hepatic and renal impairment. Lactation: Agent is distributed into breast milk; use with caution.
Hypersensitivity; acute attack of gout.
Pregnancy category: C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks
Clindamycin (as phosphate)
Clindamycin (as phosphate)
Clindamycin (as phosphate)
Clindamycin (as phosphate)
Clindamycin (as phosphate)
Clindamycin (as phosphate)
Clindamycin (as phosphate)
Clindamycin (as phosphate)